Screening (medicine)

Medical screening is a strategic method used to identify unrecognized health conditions or risk markers. Unlike diagnostic testing, screening is applied to people who do not yet show any symptoms or signs of disease. The primary goal is to find conditions that might develop into serious illnesses in the future. By identifying these issues early, medical professionals can begin management and intervention sooner. This early action aims to reduce both suffering and mortality rates for various diseases.

There are several distinct ways to organize a screening program. Mass screening, also called population-based screening, involves testing an entire population or a specific subgroup. This method is offered to everyone in that group regardless of their individual risk levels. Another approach is high-risk or targeted screening, which focuses only on people with specific risk factors. For example, case finding might involve testing a person because a family member has a hereditary disease. Some programs use multiphasic screening, which applies two or more different tests to a large group at once. This allows researchers to look for multiple conditions simultaneously rather than running separate tests for each disease.

To ensure screening is effective, experts follow specific scientific principles. In 1968, the World Health Organization (WHO) published guidelines known as the Wilson and Jungner criteria. These rules state that the condition being screened must be an important health problem. There must also be an available treatment and a way to diagnose the condition. Furthermore, the disease should have a latent stage, which is a period where it exists but shows no symptoms. The test itself must be acceptable to the population being studied. Finally, the cost of finding cases must be economically balanced against total medical spending.

As technology has advanced, these principles have evolved to meet new challenges. In 2008, the WHO synthesized and modified the original criteria to include new genomic technologies. Modern screening programs must now define clear objectives and target populations from the very start. There must be scientific evidence proving the program is actually effective. These programs should integrate education, testing, and clinical services into one cohesive system. Quality assurance is also required to minimize potential risks to the participants. Modern standards emphasize informed consent, confidentiality, and respect for personal autonomy.

Many different types of screening occur in everyday medical practice. Common examples include mammography to detect breast cancer and colonoscopies to find colorectal cancer. Doctors also use the PPD test to screen for exposure to tuberculosis. In schools, students in the United States are often screened for vision, hearing, and dental problems. Some regions even screen for scoliosis, though this remains a controversial practice. Beyond physical health, some programs now screen for social determinants of health. These are economic and social conditions, like education or income, that influence a person's well-being.

While screening can save lives, it is important to understand its limitations. Screening tests are not designed to be diagnostic, meaning they do not provide a final confirmation. Because of this, they often produce false positive or false negative results. A false positive occurs when a test incorrectly suggests a person has a condition they do not actually have. This can lead to misdiagnosis, unnecessary medical investigations, and significant psychological stress. A false negative occurs when a test says a person is healthy even though they are actually ill. This can create a false sense of security and delay necessary medical treatment.

Other risks associated with screening include overdiagnosis and the misuse of resources. Overdiagnosis happens when screening identifies a condition that might never have caused harm during a person's life. This can lead to unnecessary anxiety and treatment. Additionally, screening programs can cause physical discomfort or exposure to radiation and chemicals. Some experts argue that certain screenings, such as dementia screening in the UK, can cause undue anxiety without providing helpful outcomes. Therefore, the overall benefits of any screening program must always outweigh the potential harms to the population.